Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells

Bioanalysis

Volumn 5, Issue 3, 2013, Pages 327-329

  Wang, Wenyan ^a   Xu, Lingjia ^a   Kong, Jilie ^a   Fan, Huizhi ^a   Yang, Pengyuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; PEPTIDE;

ANALYTIC METHOD; ARTICLE; CARCINOMA CELL; CELL STRAIN; CELL STRAIN 97L; CELL STRAIN HEPG2; CELL STRAIN L02; CELL STRAIN LM3; CHROMATOGRAPHY; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MASS SPECTROMETER; MASS SPECTROMETRY; METASTASIS; METASTASIS POTENTIAL; PROTEIN METHYLATION; PROTEIN PROCESSING; QUANTITATIVE STUDY;

ACETYLATION; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHROMATOGRAPHY, LIQUID; DEUTERIUM; HEP G2 CELLS; HISTONES; HUMANS; ISOTOPE LABELING; LIVER NEOPLASMS; METHYLATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84873578376     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.324     Document Type: Article

References (26)

1. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403(6765), 41-45 (2000
2. Ito T. Role of histone modification in chromatin dynamics. J. Biochem. 141(5), 609-614 (2007
3. Zhang Y, Lv J, Liu HB et al. HHMD: The human histone modification database. Nucleic Acids Res. 38(Suppl. 1), D149-D154 (2010
4. Walia H, Chen HY, Sun JM et al. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. J. Biol. Chem. 273(23), 14516-14522 (1998
5. Hansen JC, Tse C, Wolffe AP. Structure and function of the core histone N-termini: More than meets the eye. Biochemistry 37(51), 17637-17641 (1998
6. Durrin LK, Mann RK, Kayne PS et al. Yeast histone H4 N-terminal sequence is required for promoter activation in vivo. Cell 65(6), 1023-1031 (1991
7. Villar-Garea A, Imhof A. The analysis of histone modifications. Biochim. Biophys. Acta 1764(12), 1932-1939 (2006
8. Young NL, Dimaggio PA, Garcia BA. The significance, development and progress of high-throughput combinatorial histone code analysis. Cell. Mol. Life Sci. 67(23), 3983-4000 (2010
9. Espino PS, Drobic B, Dunn KL et al. Histone modifications as a platform for cancer therapy. J. Cell. Biochem. 94(6), 1088-1102 (2005
10. Elsheikh SE, Green AR, Rakha EA et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69(9), 3802-3809 (2009
11. Seligson DB, Horvath S, Mcbrian MA et al. Global levels of histone modifications predict prognosis in different cancers. Am. J. Pathol. 174(5), 1619-1628 (2009
12. Ellinger J, Kahl P, Rogenhofer S et al. Global levels of histone modifications predict prostate cancer recurrence. Prostate 70(1), 61-69 (2010
13. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer 94(2), 153-156 (2001
14. Tang ZY, Ye SL, Liu YK et al. A decade's studies on metastasis of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130(4), 187-196 (2004
15. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10), 994-999 (1999
16. Goodlett DR, Keller A, Watts JD et al. Differential stable isotope labeling of peptides for quantitation and de novo sequence derivation. Rapid Commun. Mass Spectrom. 15(14), 1214-1221 (2001
17. Tang LY, Deng N, Wang LS et al. Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network. Mol. Cell. Proteomics 6(11), 1952-1967 (2007
18. Xie LQ, Zhao C, Cai SJ et al. Novel proteomic strategy reveal combined a1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J. Proteome Res. 9(9), 4701-4709 (2010
19. Shechter D, Dormann HL, Allis CD et al. Extraction, purification and analysis of histones. Nat. Protoc. 2(6), 1445-1457 (2007
20. Nie AY, Lu HJ, Yang PY, He FC. Comprehensive profiling for histone H4 of human liver cells using high resolution LTQ-Orbitrap mass spectrometry. Chin. J. Chem. 29(1), 171-177 (2011
21. Thomas CE, Kelleher NL, Mizzen CA. Mass spectrometric characterization of human histone H3: A bird's eye view. J. Proteome Res. 5(2), 240-247 (2006
22. Young NL, DiMaggio PA, Plazas-Mayorca MD et al. High throughput characterization of combinatorial histone codes. Mol. Cell. Proteomics 8(10), 2266-2284 (2009
23. Ong SE, Blagoev B, Mann M et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1(5), 376-386 (2002
24. Ficarro SB, McCleland ML, Stukenberg PT et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20(3), 301-305 (2002
25. Hake SB, Garcia BA, Duncan EM et al. Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J. Biol. Chem. 281(1), 559-568 (2006
26. Garcia BA, Hake SB, Diaz RL et al. Organismal differences in post-translational modifications in histones H3 and H4. J. Biol. Chem. 282(10), 7641-7655 (2007